Antidepressant Use May Speed Up Cognitive Decline in Patients With Dementia
By Elana Gotkine HealthDay Reporter
WEDNESDAY, March 5, 2025 -- Current antidepressant use is associated with faster cognitive decline in patients with dementia, according to a study published online Feb. 25 in BMC Medicine.
Minjia Mo, Ph.D., from the Karolinska Institutet in Stockholm, and colleagues examined the association between antidepressants and cognitive decline in patients with dementia in a national cohort study. Data were included for 18,740 patients, of whom 22.8 percent received at least one prescription for an antidepressant.
The researchers found that 11,912 prescriptions for antidepressants were issued during follow-up, with selective serotonin reuptake inhibitors (SSRI) being the most common (64.8 percent). Compared with nonuse, there was an association for antidepressant use with faster cognitive decline (β = −0.30 points/year), especially for sertraline, citalopram, escitalopram, and mirtazapine (β = −0.25, −0.41, −0.76, and −0.19 points/year, respectively). Patients with severe dementia (initial Mini-Mental State Examination scores 0 to 9) had a stronger association. A greater rate of decline was seen for escitalopram than sertraline. Dose response of SSRIs on greater cognitive decline and higher risks for severe dementia, all-cause mortality, and fracture were seen compared with nonuse.
"Our study cannot distinguish whether these findings are due to the antidepressants or the underlying psychiatric indication," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted March 2025
Read this next
Random Forest AI Model Superior for Inpatient Mortality Prognostication in Cirrhosis
THURSDAY, July 24, 2025 -- For inpatients with cirrhosis, a machine learning (ML) model using random forest (RF) analysis is superior for prediction of inpatient mortality...
Inflammation and Nutrition-Based Scores Tied to Prognosis of Low-Risk Myelodysplastic Syndrome
THURSDAY, July 24, 2025 -- The Prognostic Nutritional Index (PNI) and systemic oxidative stress (SOS) score are independently associated with poorer prognosis of low-risk...
Few School Principals Report District-Mandated Mental Health Screening
THURSDAY, July 24, 2025 -- Few school principals report district-mandated mental health screening in schools, according to a study published online July 18 in JAMA Network...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.